Efficacy of Prehabilitation in cancer patients: an Rcts systematic review with meta-analysis.

IF 3.4 2区 医学 Q2 ONCOLOGY BMC Cancer Pub Date : 2024-10-22 DOI:10.1186/s12885-024-13023-w
Daniele Gennuso, Angela Baldelli, Loredana Gigli, Ilaria Ruotolo, Giovanni Galeoto, Daniela Gaburri, Giovanni Sellitto
{"title":"Efficacy of Prehabilitation in cancer patients: an Rcts systematic review with meta-analysis.","authors":"Daniele Gennuso, Angela Baldelli, Loredana Gigli, Ilaria Ruotolo, Giovanni Galeoto, Daniela Gaburri, Giovanni Sellitto","doi":"10.1186/s12885-024-13023-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Patients with cancer (PwC) who undergo specific treatments reported greater fatigue and reduced functional capacity as predominant outcomes, compromising their QoL during and following the treatment. Prehabilitation intervention, provided after diagnosis and before treatments, is to optimize the physiological reserve and address modifiable risk factors before surgery or chemotherapy to improve post-treatment results. The primary aim of this study is to obtain a common line of efficacy compared with prehabilitation treatment; the secondary endpoint is to assess the methodological quality of the studies eligible in the review.</p><p><strong>Methods: </strong>The systematic review was conducted from September to February 2024, in accordance with PRISMA guidelines. Databases consulted were MEDLINE, Scopus, Web of science and CINAHL, RCTs related to Prehabilitation intervention on PwC were included. The methodological quality of the included studies was assessed through the RoB2 Cochrane tool and the PEDro scale. Meta-analysis was performed to estimate relative treatment effects among evaluated outcomes.</p><p><strong>Results: </strong>Forty-two studies were included in the systematic review, 13 were included in the quantitative analysis. The results of the studies reporting reduced postoperative hospital stay, improved endurance, muscle strength, respiratory function, quality of life, and urinary incontinence. Critical analysis of the articles using the PEDro scale revealed 28 RCTs with a good rating, 9 with a fair rating, and 5 with a poor rating; in contrast, the Cochrane RoB2 tool revealed that all articles were at high risk of bias. Meta-analysis showed statistically significant values for 6MWT (38.53, 95%CI 33.03 - 44.04); HADS-depression (-0.71, 95%CI -0.93 -0.49) and HADS-anxiety (-0.49, 95%CI -0.76 -0.23).</p><p><strong>Conclusions: </strong>Prehabilitation represents a specific intervention that aims to improve postoperative outcomes in fragile patients undergoing surgery, increasing their preoperative physiological reserve in anticipation of the stress they will face and facilitating the postoperative recovery of functional capacity. Prehabilitation is a good intervention to use, especially in terms of functional capacity and mental health, the latter being very impactful in terms of reduced levels of anxiety and depression. These data make it possible to justify supportive intervention by physical therapists aimed at improving and restoring health-related QoL especially in the short term.</p>","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11494964/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12885-024-13023-w","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Patients with cancer (PwC) who undergo specific treatments reported greater fatigue and reduced functional capacity as predominant outcomes, compromising their QoL during and following the treatment. Prehabilitation intervention, provided after diagnosis and before treatments, is to optimize the physiological reserve and address modifiable risk factors before surgery or chemotherapy to improve post-treatment results. The primary aim of this study is to obtain a common line of efficacy compared with prehabilitation treatment; the secondary endpoint is to assess the methodological quality of the studies eligible in the review.

Methods: The systematic review was conducted from September to February 2024, in accordance with PRISMA guidelines. Databases consulted were MEDLINE, Scopus, Web of science and CINAHL, RCTs related to Prehabilitation intervention on PwC were included. The methodological quality of the included studies was assessed through the RoB2 Cochrane tool and the PEDro scale. Meta-analysis was performed to estimate relative treatment effects among evaluated outcomes.

Results: Forty-two studies were included in the systematic review, 13 were included in the quantitative analysis. The results of the studies reporting reduced postoperative hospital stay, improved endurance, muscle strength, respiratory function, quality of life, and urinary incontinence. Critical analysis of the articles using the PEDro scale revealed 28 RCTs with a good rating, 9 with a fair rating, and 5 with a poor rating; in contrast, the Cochrane RoB2 tool revealed that all articles were at high risk of bias. Meta-analysis showed statistically significant values for 6MWT (38.53, 95%CI 33.03 - 44.04); HADS-depression (-0.71, 95%CI -0.93 -0.49) and HADS-anxiety (-0.49, 95%CI -0.76 -0.23).

Conclusions: Prehabilitation represents a specific intervention that aims to improve postoperative outcomes in fragile patients undergoing surgery, increasing their preoperative physiological reserve in anticipation of the stress they will face and facilitating the postoperative recovery of functional capacity. Prehabilitation is a good intervention to use, especially in terms of functional capacity and mental health, the latter being very impactful in terms of reduced levels of anxiety and depression. These data make it possible to justify supportive intervention by physical therapists aimed at improving and restoring health-related QoL especially in the short term.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
癌症患者康复训练的功效:Rcts 系统回顾与荟萃分析。
背景:接受特定治疗的癌症患者(PwC)报告称,他们在治疗期间和治疗后的主要结果是更加疲劳和功能减退,影响了他们的生活质量。在确诊后和治疗前进行的预康复干预旨在优化生理储备,并在手术或化疗前解决可改变的风险因素,以改善治疗后的效果。本研究的主要目的是获得与康复前治疗相比的共同疗效;次要终点是评估符合综述条件的研究的方法学质量:系统综述于 2024 年 9 月至 2 月进行,符合 PRISMA 指南。查阅的数据库包括 MEDLINE、Scopus、Web of science 和 CINAHL,纳入了与 PwC 前期康复干预相关的 RCT。纳入研究的方法学质量通过 RoB2 Cochrane 工具和 PEDro 量表进行评估。进行了 Meta 分析,以估算评估结果中的相对治疗效果:42项研究被纳入系统综述,13项被纳入定量分析。研究结果表明,术后住院时间缩短,耐力、肌力、呼吸功能、生活质量和尿失禁得到改善。使用 PEDro 量表对文章进行批判性分析后发现,28 篇研究性临床试验获得了良好评价,9 篇获得了一般评价,5 篇获得了较差评价;而 Cochrane RoB2 工具则显示,所有文章都存在较高的偏倚风险。Meta 分析表明,6MWT(38.53,95%CI 33.03 -44.04)、HADS-抑郁(-0.71,95%CI -0.93 -0.49)和 HADS-焦虑(-0.49,95%CI -0.76 -0.23)具有显著的统计学意义:术前康复是一种特殊的干预措施,旨在改善接受手术的脆弱患者的术后效果,增加他们术前的生理储备以应对即将面临的压力,并促进术后功能的恢复。术前康复训练是一种很好的干预措施,特别是在功能能力和心理健康方面,后者对降低焦虑和抑郁水平有很大影响。这些数据证明,物理治疗师有理由采取支持性干预措施,以改善和恢复与健康相关的生活质量,尤其是在短期内。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
BMC Cancer
BMC Cancer 医学-肿瘤学
CiteScore
6.00
自引率
2.60%
发文量
1204
审稿时长
6.8 months
期刊介绍: BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.
期刊最新文献
Assessing the impact of cervical cancer education in two high schools in Ghana. Early-life antibiotic exposure aggravate the metabolic dysfunction-associated steatotic liver disease associated hepatocellular carcinoma. Efficacy and safety of PD-1/PD-L1 inhibitors in patients with Merkel Cell Carcinoma: a systematic review and Meta-analysis. Mesenchymal stem cell-derived exosomes carrying miR-486-5p inhibit glycolysis and cell stemness in colorectal cancer by targeting NEK2. Investigating the role of non-synonymous variant D67N of ADGRE2 in chronic myeloid leukemia.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1